These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 24382124

  • 1. Effect of 25 (OH) D replacements in patients with primary hyperparathyroidism (PHPT) and coexistent vitamin D deficiency on serum 25(OH) D, calcium and PTH levels: a meta-analysis and review of literature.
    Shah VN, Shah CS, Bhadada SK, Rao DS.
    Clin Endocrinol (Oxf); 2014 Jun; 80(6):797-803. PubMed ID: 24382124
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of common vitamin D supplementation in primary hyperparathyroidism and coexistent vitamin D deficiency and insufficiency: a systematic review and meta-analysis.
    Song A, Zhao H, Yang Y, Liu S, Nie M, Wang O, Xing X.
    J Endocrinol Invest; 2021 Aug; 44(8):1667-1677. PubMed ID: 33453021
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency.
    Grey A, Lucas J, Horne A, Gamble G, Davidson JS, Reid IR.
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2122-6. PubMed ID: 15644400
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A very high incidence of low 25 hydroxy-vitamin D serum concentration in a French population of patients with primary hyperparathyroidism.
    Boudou P, Ibrahim F, Cormier C, Sarfati E, Souberbielle JC.
    J Endocrinol Invest; 2006 Jun; 29(6):511-5. PubMed ID: 16840828
    [Abstract] [Full Text] [Related]

  • 18. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
    Giusti A, Barone A, Pioli G, Girasole G, Razzano M, Pizzonia M, Pedrazzoni M, Palummeri E, Bianchi G.
    J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mild primary hyperparathyroidism: vitamin D deficiency and cardiovascular risk markers.
    Farahnak P, Lärfars G, Sten-Linder M, Nilsson IL.
    J Clin Endocrinol Metab; 2011 Jul; 96(7):2112-8. PubMed ID: 21593116
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.